Balu Kamaraj Selected Research

type 1 Atelosteogenesis

11/2020

Deciphering the Role of Filamin B Calponin-Homology Domain in Causing the Larsen Syndrome, Boomerang Dysplasia, and Atelosteogenesis Type I Spectrum Disorders via a Computational Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Balu Kamaraj Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 12/2013
3	Albinism 11/2016 - 01/2014
3	Oculocutaneous albinism type 2 12/2014 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2019 - 12/2014
2	Oculocutaneous Albinism (Albinism, Yellow Mutant) 12/2014 - 01/2014
1	Chronic Disease (Chronic Diseases) 01/2022
1	Dental Caries (Decay, Dental) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Staphylococcal Infections 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Leukemia 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Boomerang dysplasia 11/2020
1	Larsen Syndrome 11/2020
1	type 1 Atelosteogenesis 11/2020
1	COVID-19 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Infections 01/2020
1	HIV Infections (HIV Infection) 01/2020
1	Lysinuric Protein Intolerance 10/2019
1	Type IV Oculocutaneous Albinism 11/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015
1	Liposarcoma 01/2015
1	Hypopigmentation (Hypomelanosis) 12/2014
1	Ocular Albinism 12/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Rufous oculocutaneous albinism 01/2013

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
5	Melanins (Melanin)IBA 11/2016 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2015
3	MicroRNAs (MicroRNA)IBA 12/2014 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 12/2014 - 01/2014
2	3' Untranslated Regions (3' UTR)IBA 12/2014 - 01/2014
1	BRCA1 ProteinIBA 01/2022
1	Chloride Channels (Chloride Channel)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 07/2021
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2021
1	CalponinsIBA 11/2020
1	FilaminsIBA 11/2020
1	Reverse Transcriptase InhibitorsIBA 01/2020
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2020
1	NucleosidesIBA 01/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2020
1	vapreotideIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2019
1	Diamino Amino AcidsIBA 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2015
1	Proline (L-Proline)FDA Link 01/2015
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2015
1	RNA-Binding Protein FUSIBA 01/2015
1	A-Form DNA (A-DNA)IBA 01/2015
1	Untranslated Regions (Untranslated Region)IBA 01/2014
1	Peptides (Polypeptides)IBA 12/2013
1	Polo-Like Kinase 1IBA 12/2013

Therapy/Procedure

1	Precision Medicine 01/2014
1	Drug Therapy (Chemotherapy) 12/2013